Home Page Potential Lawsuit Human Genome Sciences Inc
Human Genome Sciences Inc HGSI 401(k) / ERISA LawsuitHuman Genome Sciences Inc has been accused of securities fraud. If you are a current or former employee or are a member of any of Human Genome Sciences Inc investment plans or profit sharing retirement plans you may be included in this possible Human Genome Sciences Inc 401(k) or Employee Retirement Income Security Act (ERISA) class action. If you purchased or held Human Genome Sciences Inc stock in one of those plans during the periods Jul-20-09 to Nov-11-10, you may have a claim.
Under ERISA, Human Genome Sciences Inc employees can file a lawsuit against the company for putting stock options at risk. Human Genome Sciences Inc employees have a claim if they can prove their employer violated its fiduciary duty to its employees. Fiduciary duty refers to a company's responsibility to the people who invest in it. If an employer puts the company's interest ahead of the investors', it has broken its fiduciary duty. A fiduciary is a person that exercises discretion over the management of plan assets or exercises discretionary control over the administration of the plan.
ERISA is a federal law that sets minimum standards for pension and health plans set up by private businesses. ERISA was designed to protect people who participate in employee benefit plans, including employees with stock options in a company. Stock options are a form of compensation in which employees are given the opportunity to purchase shares of the company stock at a certain price.
Human Genome Sciences Inc 401(k) / ERISA Legal HelpIf you have suffered from Human Genome Sciences Inc 401(k) plan losses, you may qualify for damages or remedies that may be awarded in a possible Human Genome Sciences Inc ERISA class action lawsuit. Please click the link below to submit your complaint and we will have a lawyer review your ERISA complaint.
Last updated on Mar-23-12
READ MORE [ Employment Settlements and Legal News ]
READ MORE [ Securities Settlements and Legal News ]
ADD YOUR COMMENT ON THIS ISSUE